Pharmaceutical Products Total — Revenue
Eli Lilly Pharmaceutical Products Total — Revenue increased by 2.6% to $19.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.5%, from $12.73B to $19.80B. Over 4 years (FY 2021 to FY 2025), Pharmaceutical Products Total — Revenue shows an upward trend with a 23.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase reflects strong market adoption and successful commercial execution, while a decrease may signal loss of market share or patent expirations.
Detailed definition
This metric measures the total gross sales generated by the pharmaceutical products segment, reflecting the market deman...
Peer comparison
Directly comparable to the 'Pharmaceutical Segment Revenue' reported by major global pharmaceutical competitors.
lly_segment_pharmaceutical_products_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.74B | $6.77B | $8.00B | $7.81B | $6.49B | $6.94B | $7.30B | $6.96B | $8.31B | $9.50B | $9.35B | $8.77B | $11.30B | $11.44B | $13.53B | $12.73B | $15.56B | $17.60B | $19.29B | $19.80B |
| QoQ Change | — | +0.5% | +18.1% | -2.4% | -16.9% | +7.0% | +5.2% | -4.7% | +19.4% | +14.3% | -1.5% | -6.3% | +28.9% | +1.2% | +18.3% | -5.9% | +22.2% | +13.1% | +9.6% | +2.6% |
| YoY Change | — | — | — | — | -3.7% | +2.5% | -8.7% | -10.9% | +28.1% | +36.8% | +28.1% | +26.0% | +36.0% | +20.4% | +44.7% | +45.2% | +37.6% | +53.9% | +42.6% | +55.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's pharmaceutical products total — revenue?
- Eli Lilly (LLY) reported pharmaceutical products total — revenue of $19.80B in Q1 2026.
- How has Eli Lilly's pharmaceutical products total — revenue changed year-over-year?
- Eli Lilly's pharmaceutical products total — revenue increased by 55.5% year-over-year, from $12.73B to $19.80B.
- What is the long-term trend for Eli Lilly's pharmaceutical products total — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's pharmaceutical products total — revenue has grown at a 23.2% compound annual growth rate (CAGR), from $28.32B to $65.18B.
- What does pharmaceutical products total — revenue mean?
- The total revenue generated from the sale of pharmaceutical products.